BERLIN (Reuters) – Siemens Healthineers confirmed its full-year outlook on Thursday despite a drop in quarterly profit driven by low demand in China, as it saw strong order growth in the first q[...]
Read more
Health
Roche warns 2023 profits will fall on $5 billion COVID sales hit
By Ludwig Burger BASEL (Reuters) – Roche warned on Thursday profits will decline in 2023 as falling demand for its COVID-19 therapy and diagnostics kits will knock sales by over $5 billion, the[...]
Read more
Japan’s Takeda’s profit slips 13%, pipeline bolsters outlook
TOKYO (Reuters) – Japan’s Takeda Pharmaceutical Co posted a 13% drop in operating earnings for the nine months ended December but kept its profit outlook for the fiscal year unchanged as i[...]
Read more
GSK gives few clues on plans to replenish medicine cabinet
By Natalie Grover and Maggie Fick LONDON (Reuters) -GSK chief executive Emma Walmsley on Wednesday made replenishing the drugmaker’s pipeline of vaccines and therapies her number-one priority. B[...]
Read more
AbbVie’s Humira gets a U.S. rival, but costs could stay high
By Patrick Wingrove (Reuters) – U.S. patients will finally get access to cheaper versions of AbbVie Inc’s blockbuster arthritis drug Humira this year, but the cost savings are expected to be lim[...]
Read more
Novartis says operating profit to grow again ahead of Sandoz spin-off
By Ludwig Burger BASEL (Reuters) – Novartis on Wednesday predicted that core operating income would grow in a “mid single digit” percentage range in 2023 following stagnation last ye[...]
Read more
GSK beats expectations, shingles vaccine bolsters outlook
By Maggie Fick and Natalie Grover (Reuters) – GSK on Wednesday beat fourth-quarter profit and sales forecasts helped by sales of its blockbuster shingles vaccine Shingrix and unveiled an upbeat[...]
Read more
Pfizer sees steep 2023 fall in COVID sales, aims to bolster pipeline
By Bhanvi Satija and Michael Erman (Reuters) – Pfizer Inc on Tuesday forecast a bigger-than-expected drop in sales of its COVID-19 vaccine and treatment for 2023, intensifying investor concerns[...]
Read more
Bayer under investor pressure to speed up CEO changeover
By Patricia Weiss and Ludwig Burger FRANKFURT (Reuters) – A top-10 shareholder in Bayer on Tuesday called on the group’s supervisory board to replace chief executive Werner Baumann quickly[...]
Read more